All Stories

  1. Effects of Sample Deposition Medium and Drying on Spectroscopic Quantification of Lipid Biomarkers in Respiratory Distress Syndrome

    Article • Biosensors, March 2026, MDPI AG

    Professor Ahilanandan Dushianthan

  2. Fabrication of cellophane-based microfluidic devices using laser direct-write approach

    Article • March 2026, SPIE

    Professor Ahilanandan Dushianthan

  3. Identification and antimicrobial susceptibility testing of MRSA using miniaturized fluidic wells laser-patterned on transparent substrate

    Article • March 2026, SPIE

    Professor Ahilanandan Dushianthan

  4. Expression of cell-surface activation markers on human CD15+ cells after selected non esterified fatty acid supplementations

    Article • Lipids in Health and Disease, September 2025, Springer Science + Business Media

    Dr Alan Nigel Hunt, Professor Ahilanandan Dushianthan

  5. The role of corticosteroids in the management of non-COVID-19 severe community-acquired pneumonia in the intensive care unit: A narrative review

    Article • Journal of the Intensive Care Society, September 2025, SAGE Publications

    Professor Ahilanandan Dushianthan

  6. Hyperoxia and Surfactant Dysfunction in Critical Illness: Insights and Future Therapeutic Prospects

    Article • American Journal of Respiratory Cell and Molecular Biology, September 2025, American Thoracic Society

    Professor Ahilanandan Dushianthan

  7. Severe viral infections requiring intensive care unit admissions- aetiology, co-infections, respiratory interventions and outcomes

    Article • Infection, September 2025, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  8. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients

    Article • JAMA, August 2025, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  9. Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients

    Article • JAMA, July 2025, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  10. Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness

    Article • JAMA Network Open, May 2025, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  11. Improving physical function with physiotherapy assistants following intensive care unit admission (EMPRESS): A randomised controlled feasibility study

    Article • Journal of the Intensive Care Society, May 2025, SAGE Publications

    Professor Ahilanandan Dushianthan

  12. Evaluation of the physiological variables and scoring systems at intensive care discharge as predictors of clinical deterioration and readmission: a single-centre retrospective study

    Article • BMJ Open, May 2025, BMJ

    Professor Ahilanandan Dushianthan

  13. Corticosteroids for the management of severe community-acquired pneumonia: A UK-wide survey

    Article • Journal of the Intensive Care Society, March 2025, SAGE Publications

    Professor Ahilanandan Dushianthan

  14. The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis

    Article • Journal of Antimicrobial Chemotherapy, March 2025, Oxford University Press (OUP)

    Professor Ahilanandan Dushianthan

  15. Lung Ultrasound in Critical Care: A Narrative Review

    Article • Diagnostics, March 2025, MDPI AG

    Professor Ahilanandan Dushianthan

  16. Physiology and pathophysiology of mucus and mucolytic use in critically ill patients

    Article • Critical Care, February 2025, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  17. Pre-Hospital Critical Care for Out-of-Hospital Cardiac Arrests with Return of Spontaneous Circulation: A Retrospective Observational Study

    Article • Journal of Clinical Medicine, February 2025, MDPI AG

    Professor Ahilanandan Dushianthan

  18. Immunoglobulin unresponsive Guillain-Barré syndrome: rinse or repeat? A systematic review

    Article • BMJ Neurology Open, February 2025, BMJ

    Professor Ahilanandan Dushianthan

  19. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study

    Article • F1000Research, December 2024, Faculty of 1000, Ltd.

    Professor Ahilanandan Dushianthan

  20. Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU)

    Article • Pathogens, November 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  21. Management of adult mechanically ventilated patients: A UK-wide survey

    Article • Journal of the Intensive Care Society, October 2024, SAGE Publications

    Professor Ahilanandan Dushianthan

  22. Best Abstracts

    Article • Intensive Care Medicine Experimental, October 2024, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  23. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study

    Article • F1000Research, October 2024, Faculty of 1000, Ltd.

    Professor Ahilanandan Dushianthan

  24. Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation

    Article • International Journal of Molecular Sciences, September 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  25. Characteristics, Management, and Outcomes of Acute Life-Threatening Asthma in Adult Intensive Care

    Article • Clinics and Practice, September 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  26. Intensive Care Management of Severe Hyponatraemia—An Observational Study

    Article • Medicina, August 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  27. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study

    Article • F1000Research, August 2024, Faculty of 1000, Ltd.

    Professor Ahilanandan Dushianthan

  28. Towards quantifying biomarkers for respiratory distress in preterm infants: Machine learning on mid infrared spectroscopy of lipid mixtures

    Article • Talanta, August 2024, Elsevier

    Professor Ahilanandan Dushianthan

  29. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation

    Article • NIHR Open Research, July 2024, National Institute for Health Research

    Professor Ahilanandan Dushianthan

  30. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study

    Article • F1000Research, June 2024, Faculty of 1000, Ltd.

    Professor Ahilanandan Dushianthan

  31. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications

    Article • Diagnostics, May 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  32. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation

    Article • NIHR Open Research, April 2024, National Institute for Health Research

    Professor Ahilanandan Dushianthan

  33. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications

    Article • April 2024, MDPI AG

    Professor Ahilanandan Dushianthan, Zixing (Hings) Luo

  34. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

    Article • Nature Communications, April 2024, Springer Science + Business Media

    Professor Ahilanandan Dushianthan, Dr Cherie Armour, Dr dan Wootton

  35. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

    Article • Nature Immunology, April 2024, Springer Science + Business Media

    Professor Ahilanandan Dushianthan, MD Pilar Rivera Ortega, Dr Cherie Armour, Dr dan Wootton

  36. In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome

    Article • Cells, February 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  37. Management of Acute Life-Threatening Asthma Exacerbations in the Intensive Care Unit

    Article • Applied Sciences, January 2024, MDPI AG

    Professor Ahilanandan Dushianthan

  38. Characterization of Binary Liposome with Raman Spectroscopy for Targeted Nanomedicine

    Article • January 2024, Optical Society of America (OSA)

    Professor Ahilanandan Dushianthan

  39. Non-Invasive Ventilation for Community-Acquired Pneumonia: Outcomes and Predictors of Failure from an ICU Cohort

    Article • Medicina, December 2023, MDPI AG

    Professor Ahilanandan Dushianthan

  40. Organisation and delivery of a dedicated multidisciplinary prone ventilation team in the intensive care unit: Strategies and lessons from COVID-19

    Article • PLOS One, December 2023, PLOS

    Professor Ahilanandan Dushianthan

  41. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19

    Article • The Journal of Infectious Diseases, December 2023, Oxford University Press (OUP)

    Professor Ahilanandan Dushianthan, Dr dan Wootton

  42. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

    Article • Nature Communications, December 2023, Springer Science + Business Media

    Professor Ahilanandan Dushianthan, Dr dan Wootton

  43. Simvastatin in Critically Ill Patients with Covid-19

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 2023, New England Journal of Medicine (NEJM/MMS)

    Professor Ahilanandan Dushianthan

  44. A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)

    Article • Scientific Reports, November 2023, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  45. Severe Parainfluenza Viral Infection—A Retrospective Study of Adult Intensive Care Patients

    Article • Journal of Clinical Medicine, November 2023, MDPI AG

    Professor Ahilanandan Dushianthan

  46. Intravenous Vitamin C for Patients Hospitalized With COVID-19

    Article • JAMA, November 2023, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  47. Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia

    Article • Medical Sciences, November 2023, MDPI AG

    Professor Ahilanandan Dushianthan

  48. International Pediatric COVID-19 Severity Over the Course of the Pandemic

    Article • JAMA Pediatrics, October 2023, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan, Prof. Dr Nicole Ritz, Stephania Cormier

  49. Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions

    Article • Diagnostics, September 2023, MDPI AG

    Professor Ahilanandan Dushianthan

  50. Predictors of mortality for major trauma patients in intensive care: A retrospective cohort study

    Article • F1000Research, August 2023, Faculty of 1000, Ltd.

    Professor Ahilanandan Dushianthan

  51. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial

    Article • American Review of Respiratory Disease, August 2023, American Thoracic Society

    Professor Ahilanandan Dushianthan, Dr Anna Krasnodembskaya

  52. Prone Positioning in Mechanically Ventilated COVID-19 Patients: Timing of Initiation and Outcomes

    Article • Journal of Clinical Medicine, June 2023, MDPI AG

    Professor Ahilanandan Dushianthan

  53. Provision of Microbiology, Infection Services and Antimicrobial Stewardship in Intensive Care: A Survey across the Critical Care Networks in England and Wales

    Article • Antibiotics, April 2023, MDPI AG

    Professor Ahilanandan Dushianthan

  54. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

    Article • JAMA, April 2023, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  55. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection

    Article • March 2023, Springer Science + Business Media

    Professor Ahilanandan Dushianthan, Dr Alistair C Darby, Dr dan Wootton

  56. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

    Article • JAMA, January 2023, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  57. Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure

    Article • Cureus, December 2022, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  58. The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial

    Article • Anaesthesia, December 2022, Wiley

    Professor Ahilanandan Dushianthan, Dale Vimalachandran

  59. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial

    Article • Journal of Infection, December 2022, Elsevier

    Professor Ahilanandan Dushianthan

  60. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Article • EBioMedicine, December 2022, Elsevier

    MD Pilar Rivera Ortega, Mark Philip Cassar, Prof. Markus Ralser, Professor Ahilanandan Dushianthan, Dr Cherie Armour, Dr Stephen P McAdoo, Dr dan Wootton

  61. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19

    Article • Immunology, November 2022, Wiley

    Professor Ahilanandan Dushianthan

  62. S44 Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID trial): 1 year follow up for safety and pulmonary dysfunction

    Article • November 2022, BMJ

    Professor Ahilanandan Dushianthan

  63. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study

    Article • Open Forum Infectious Diseases, October 2022, Oxford University Press (OUP)

    Professor Ahilanandan Dushianthan, Dr dan Wootton

  64. Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon

    Article • Clinical Nutrition ESPEN, October 2022, Elsevier

    Professor Ahilanandan Dushianthan

  65. Aspergillus in COVID-19 intensive care unit; what is lurking above your head?

    Article • Journal of Infection Prevention, September 2022, SAGE Publications

    Professor Ahilanandan Dushianthan

  66. Caring for COVID‐19 patients through a pandemic in the intensive care setting: A narrative review

    Article • WIREs Mechanisms of Disease, July 2022, Wiley

    Professor Ahilanandan Dushianthan

  67. Antimicrobial stewardship programmes focused on de-escalation: a narrative review of efficacy and risks

    Article • Journal of Emergency and Critical Care Medicine, July 2022, AME Publishing Company

    Professor Ahilanandan Dushianthan

  68. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study

    Article • PLOS One, June 2022, PLOS

    Prof Michael M Grocott, Professor Ahilanandan Dushianthan

  69. Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission

    Article • Open Forum Infectious Diseases, May 2022, Oxford University Press (OUP)

    Professor Ahilanandan Dushianthan

  70. Plasma and Airway Levels of Surfactant Protein D Degradation Reflect Progression of ARDS in Ventilated Patients with SARS-CoV-2

    Article • May 2022, American Thoracic Society

    Professor Ahilanandan Dushianthan

  71. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cell Administration (REALIST-COVID) Phase 2 Randomised Controlled Trial

    Article • May 2022, American Thoracic Society

    Professor Ahilanandan Dushianthan

  72. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study

    Article • Scientific Reports, April 2022, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  73. Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19

    Article • JAMA, April 2022, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  74. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19

    Article • Journal of Intensive Care Medicine, April 2022, SAGE Publications

    Professor Ahilanandan Dushianthan

  75. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

    Article • The Lancet Digital Health, April 2022, Elsevier

    Professor Ahilanandan Dushianthan, Dr dan Wootton

  76. Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial

    Article • BMJ Open, April 2022, BMJ

    Professor Ahilanandan Dushianthan, Prof Nicholas Hart

  77. Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

    Article • The Clinical Respiratory Journal, February 2022, Wiley

    Professor Ahilanandan Dushianthan

  78. Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial

    Article • American Review of Respiratory Disease, February 2022, American Thoracic Society

    Professor Ahilanandan Dushianthan

  79. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

    Article • Cell, February 2022, Elsevier

    Michael Olanipekun, Professor Ahilanandan Dushianthan, Dr dan Wootton

  80. Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital

    Article • BMJ Open, February 2022, BMJ

    Professor Ahilanandan Dushianthan

  81. Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics

    Article • Journal of Clinical Virology, January 2022, Elsevier

    Professor Ahilanandan Dushianthan

  82. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19

    Article • Heart, December 2021, BMJ

    Michael Olanipekun, Professor Ahilanandan Dushianthan

  83. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

    Article • Thorax, November 2021, BMJ

    Professor Ahilanandan Dushianthan

  84. Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19

    Article • JAMA, November 2021, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  85. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

    Article • iScience, November 2021, Elsevier

    Michael Olanipekun, Professor Ahilanandan Dushianthan, Dr Marlies Ostermann, Dr dan Wootton

  86. A prenylated dsRNA sensor protects against severe COVID-19

    Article • Science, October 2021, American Association for the Advancement of Science

    Professor Ahilanandan Dushianthan, Professor Ruth Frances Jarrett

  87. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study

    Article • Nephrology Dialysis Transplantation, October 2021, Oxford University Press (OUP)

    Professor Ahilanandan Dushianthan

  88. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study

    Article • BMJ Open, October 2021, BMJ

    Professor Ahilanandan Dushianthan, Dr Marlies Ostermann

  89. Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?

    Article • Infezioni in Medicina, September 2021, Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche

    Professor Ahilanandan Dushianthan

  90. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2021, New England Journal of Medicine (NEJM/MMS)

    Professor Ahilanandan Dushianthan, Dr Marlies Ostermann

  91. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2021, New England Journal of Medicine (NEJM/MMS)

    Professor Ahilanandan Dushianthan

  92. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

    Article • The Lancet Microbe, August 2021, Elsevier

    Professor Ahilanandan Dushianthan, Dr dan Wootton

  93. Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit

    Article • Cureus, July 2021, Cureus, Inc.

    Professor Ahilanandan Dushianthan

  94. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

    Article • Intensive Care Medicine, July 2021, Springer Science + Business Media

    Professor Ahilanandan Dushianthan, Dr Marlies Ostermann

  95. Mapping the human genetic architecture of COVID-19

    Article • Nature, July 2021, Springer Science + Business Media

    Michael Olanipekun, Professor Ahilanandan Dushianthan, Roberta Russo, MD Massimo Girardis, Hugh Montgomery, Dr Hong Bin Kim, Lise Tuset Gustad, JUNICHI SASAKI

  96. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

    Article • The Lancet, July 2021, Elsevier

    Michael Olanipekun, Professor Ahilanandan Dushianthan, Dr Marlies Ostermann, Dr dan Wootton

  97. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

    Article • The Lancet Respiratory Medicine, July 2021, Elsevier

    Professor Ahilanandan Dushianthan

  98. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

    Article • The Lancet Rheumatology, July 2021, Elsevier

    Professor Ahilanandan Dushianthan

  99. Severe COVID-19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

    Article • June 2021, Research Square

    Professor Ahilanandan Dushianthan

  100. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England

    Article • BMC Health Services Research, June 2021, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  101. Methodology to detect oxidised phospholipids and their relevance in disease

    Article • Biochemical Society Transactions, May 2021, Portland Press Ltd.

    Professor Ahilanandan Dushianthan

  102. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

    Article • Thrombosis Research, May 2021, Elsevier

    Professor Ahilanandan Dushianthan

  103. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, April 2021, New England Journal of Medicine (NEJM/MMS)

    Professor Ahilanandan Dushianthan

  104. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

    Article • The Lancet Respiratory Medicine, April 2021, Elsevier

    Professor Ahilanandan Dushianthan

  105. Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey

    Article • Journal of the Intensive Care Society, March 2021, SAGE Publications

    Professor Ahilanandan Dushianthan, Hugh Montgomery

  106. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study

    Article • BMC Nephrology, March 2021, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  107. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

    Article • Science Immunology, March 2021, American Association for the Advancement of Science

    Professor Ahilanandan Dushianthan, Dr Marlies Ostermann

  108. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

    Article • The Lancet Respiratory Medicine, March 2021, Elsevier

    Professor Ahilanandan Dushianthan

  109. Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2021, De Gruyter

    Laurence Orchard, Professor Ahilanandan Dushianthan

  110. Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study

    Article • BMJ Open, January 2021, BMJ

    Professor Ahilanandan Dushianthan

  111. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

    Article • American Review of Respiratory Disease, December 2020, American Thoracic Society

    MD Pilar Rivera Ortega, Professor Ahilanandan Dushianthan

  112. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial

    Article • Trials, December 2020, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  113. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

    Article • Eurosurveillance, October 2020, European Centre for Disease Control and Prevention (ECDC)

    Professor Nigel James Temperton, Professor Ahilanandan Dushianthan

  114. Goal-directed haemodynamic therapy (GDHT) in surgical patients: systematic review and meta-analysis of the impact of GDHT on post-operative pulmonary complications

    Article • Perioperative Medicine, October 2020, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  115. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

    Article • JAMA, October 2020, American Medical Association (AMA)

    Professor Ahilanandan Dushianthan

  116. In-hospital cardiac arrest audit: An audit reviewing outcomes

    Article • Resuscitation, October 2020, Elsevier

    Professor Ahilanandan Dushianthan

  117. Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre

    Article • British Journal of Anaesthesia, October 2020, Elsevier

    Professor Ahilanandan Dushianthan

  118. Prediction of mortality in critically-ill elderly trauma patients: a single centre retrospective observational study and comparison of the performance of trauma scores

    Article • Scandinavian Journal of Trauma Resuscitation and Emergency Medicine, September 2020, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  119. Inflammatory phenotyping predicts clinical outcome in COVID-19

    Article • September 2020, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  120. Recurrent Pneumothorax in a Critically Ill Ventilated COVID-19 Patient

    Article • Case Reports in Critical Care, September 2020, Hindawi Publishing Corporation

    Professor Ahilanandan Dushianthan

  121. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

    Article • BMJ, September 2020, BMJ

    Professor Ahilanandan Dushianthan

  122. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit

    Article • Journal of Global Antimicrobial Resistance, September 2020, Elsevier

    Professor Ahilanandan Dushianthan

  123. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study

    Article • BMJ, August 2020, BMJ

    Professor Ahilanandan Dushianthan

  124. Conscious prone positioning during non-invasive ventilation in COVID-19 patients: experience from a single centre

    Article • F1000Research, July 2020, Faculty of 1000, Ltd.

    Professor Ahilanandan Dushianthan

  125. Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 pneumonia

    Article • British Journal of Haematology, July 2020, Wiley

    Professor Ahilanandan Dushianthan

  126. Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Professor Ahilanandan Dushianthan

  127. Clinical characteristics and outcome of critically ill COVID-19 patients with Acute Kidney Injury: A single centre cohort study

    Article • July 2020, Research Square

    Professor Ahilanandan Dushianthan

  128. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

    Article • BMJ, May 2020, BMJ

    Professor Ahilanandan Dushianthan

  129. P196 Outcome of COPD patients started on inpatient domiciliary NIV following an acute admission with hypercapnic respiratory failure

    Article • November 2019, BMJ

    Professor Ahilanandan Dushianthan

  130. Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis

    Article • Respiratory Care, September 2019, Daedalus Enterprises

    Professor Ahilanandan Dushianthan

  131. Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome

    Article • PLOS One, August 2019, PLOS

    Professor Ahilanandan Dushianthan

  132. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults

    Article • Cochrane Database of Systematic Reviews, January 2019, Wiley

    Professor Ahilanandan Dushianthan

  133. P200 A review of domiciliary non-invasive ventilation for patients with motor neurone disease (MND) in a regional centre

    Article • December 2018, BMJ

    Professor Ahilanandan Dushianthan

  134. P204 A retrospective study of home non-invasive ventilation for patients with severe COPD in a regional centre

    Article • December 2018, BMJ

    Professor Ahilanandan Dushianthan

  135. P208 The use of non-invasive ventilation in patients with community acquired pneumonia admitted to the intensive care unit

    Article • December 2018, BMJ

    Professor Ahilanandan Dushianthan

  136. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review

    Article • Perioperative Medicine, December 2018, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  137. Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome

    Article • Journal of Lipid Research, January 2018, Elsevier

    Professor Ahilanandan Dushianthan

  138. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures

    Article • Cochrane Database of Systematic Reviews, September 2017, Wiley

    Professor Ahilanandan Dushianthan

  139. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial

    Article • The Lancet Respiratory Medicine, June 2017, Elsevier

    Professor Ahilanandan Dushianthan

  140. Abstracts

    Article • Anaesthesia, January 2017, Wiley

    Professor Ahilanandan Dushianthan

  141. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults

    Article • Cochrane Database of Systematic Reviews, January 2016, Wiley

    Professor Ahilanandan Dushianthan

  142. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome

    Article • November 2014, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  143. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians

    Article • BMC Anesthesiology, October 2014, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  144. Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers

    Article • BMC Pulmonary Medicine, February 2014, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  145. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review † †This review is an abridged version of a Cochrane Review previously published in the Cochrane Database of Systematic Review...

    Article • British Journal of Anaesthesia, October 2013, Elsevier

    Professor Ahilanandan Dushianthan

  146. Proceedings of the Anaesthetic Research Society Meeting

    Article • British Journal of Anaesthesia, May 2013, Elsevier

    Professor Ahilanandan Dushianthan

  147. Perioperative buffered versus non-buffered fluid administration for surgery in adults

    Article • December 2012, Wiley

    Professor Ahilanandan Dushianthan

  148. S18 Bronchoalveolar Lavage, Tracheal Wash and Induced Sputum Surfactant Phospholipid Kinetics from Healthy Volunteers

    Article • Thorax, November 2012, BMJ

    Professor Ahilanandan Dushianthan

  149. S58 Surfactant Phospholipid Kinetics in Patients with Acute Respiratory Distress Syndrome (ARDS)

    Article • Thorax, November 2012, BMJ

    Professor Ahilanandan Dushianthan

  150. S65 Raised CK Levels in Severe Asthmatics Admitted to the Critical Care Unit- A Retrospective Cohort Analysis

    Article • Thorax, November 2012, BMJ

    Professor Ahilanandan Dushianthan

  151. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery

    Article • Cochrane Database of Systematic Reviews, November 2012, Wiley

    Professor Ahilanandan Dushianthan

  152. ESICM 2012 MONDAY SESSIONS 15 October, 2012

    Article • Intensive Care Medicine, October 2012, Springer Science + Business Media

    Eric Hoste, Professor Ahilanandan Dushianthan

  153. Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach

    Article • Journal of Cardiothoracic and Vascular Anesthesia, October 2012, Elsevier

    Professor Ahilanandan Dushianthan

  154. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?

    Article • Critical Care, January 2012, Springer Science + Business Media

    Professor Ahilanandan Dushianthan

  155. Acute respiratory distress syndrome and acute lung injury

    Article • Postgraduate Medical Journal, June 2011, BMJ

    Professor Ahilanandan Dushianthan

  156. Unusual case of unilateral whiteout on chest radiograph with evidence of previous pulmonary tuberculosis exposure

    Article • Respiratory Medicine CME, January 2011, Elsevier

    Professor Ahilanandan Dushianthan

  157. Nocturia, enuresis and snoring: an unusual combination in an adult?

    Article • British Journal of Hospital Medicine, September 2010, Mark Allen Group

    Professor Ahilanandan Dushianthan

  158. Multiple pulmonary micronodules in a patient with Crohn's disease

    Article • BMJ Case Reports, August 2010, BMJ

    Professor Ahilanandan Dushianthan

  159. Outcome Of A Cohort Of Older Population With COPD, Admitted With Hypercapnaeic Respiratory Failure And Acidosis

    Article • May 2010, American Thoracic Society

    Professor Ahilanandan Dushianthan

  160. Observed Other Primary Malignancies In Patients With Lung Cancer

    Article • May 2010, American Thoracic Society

    Professor Ahilanandan Dushianthan

  161. Summer-type relapsing fever (hypersensitivity pneumonitis) secondary to Cladosporium herbarum in the domestic environment

    Article • Respiratory Medicine CME, January 2010, Elsevier

    Professor Ahilanandan Dushianthan

  162. Developmental Regulation of p66ShcIs Altered by Bronchopulmonary Dysplasia in Baboons and Humans

    Article • American Review of Respiratory Disease, June 2005, American Thoracic Society

    Professor Ahilanandan Dushianthan

  163. Are ColonialHaemophilus influenzaeResponsible for Exacerbations of Chronic Obstructive Pulmonary Disease After All?

    Article • American Review of Respiratory Disease, January 2005, American Thoracic Society

    Professor Ahilanandan Dushianthan